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a b s t r a c t
Background: The clinical spectrum of acute coronary syndrome (ACS) has changed due to a
progressively ageing population over the last two decades.       
Aim: Weanalysed the changes in the epidemiological and treatment strategies between two           
large registries that were performed in 2005 and 2012 in well-de          ﬁned populations of the   
Czech Republic. 
Methods and results:   The CZECH-1 and CZECH-2 registries enrolled all consecutive hospital-        
ized patients with an initial diagnosis of ACS during a 1 or 2-month period, respectively.              
Thirty-six and 32 hospitals participated in the CZECH-1 and CZECH-2 registries, respectively.
A total of 1921 patients were enrolled in the CZECH-1 registry and 1221 patients participated
in the CZECH-2 registry. Patients enrolled in the CZECH-2 registry were older than those in
CZECH-1 (68  12 vs. 66  12 years; p < 0.001). ACS was not conﬁrmed during hospitalization
in 30.5 and 30.1% ( p > 0.05) of the patients in the CZECH-1 and CZECH-2 registries, respec-
tively. Urgent angiography in patients with ST segment elevation myocardial infarction
(STEMI) was performed in 92 and 94% of the patients ( p > 0.05), respectively; of these, 87 and
89% subsequently underwent primary PCI. There were no signiﬁant differences in in-
hospital (4.2 vs. 4.4%, p=0.805) or in the mortality of patients with a ﬁnal diagnosis of
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Q-myocardial (10.3 vs. 10.7%; p = 0.870) or non-Q-myocardial infarction (4.7 vs. 3.8%;
p = 0.497) between the two registries. The estimated incidence of conﬁrmed ACS and STEMI
in a representative population from both registries was 3248 and 661 cases/million indivi-
duals/year in the CZECH-1 registry and 2149 and 652 cases/million individuals/year in the
CZECH-2 registry. The fall in ACS incidence was almost exclusively due to a signiﬁcant
decrease in the incidence of unstable angina as the ﬁnal diagnosis. At discharge, the patients
with conﬁrmed ACS were administered the following medications: aspirin (95 vs. 94%;
p > 0.05), clopidogrel (60 vs. 76.4%; p < 0.001), beta-blockers (78 vs. 78%; p > 0.05), angioten-
sin-converting enzyme (ACE) inhibitors (50 vs. 78%; p = <0.001) and statins (75 vs. 90%;
p < 0.001) in the CZECH-1 and CZECH-2 registries, respectively.
Conclusion: In the Czech Republic, the age of the patients hospitalized with ACS increased
between 2005 and 2012. Invasive reperfusion strategy for patients with STEMI was very high
in both registries. The overall outcome in patients with conﬁrmed ACS did not change
between 2005 and 2012. The estimated incidence of ACS decreased due to the fall in unstable
angina pectoris.
# 2014 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp. z o.o.
All rights reserved.
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.Introduction
For the last 15 years, there has been a well-established network
of regional hospitals and tertiary centres with percutaneous
coronary intervention (PCI) capability for managing the patients
with acute coronary syndrome (ACS) in the Czech Republic.
However, progressive population ageing has also occurred
during this period, and consequently the characteristics of the
patients admitted for ACS have changed [1–3]. Two large
registries of unselected patients that were hospitalized with an
initial diagnosis of ACS were performed in 2005 and 2012 in well-
deﬁned populations of the Czech Republic [4,5]. We analysed the
changes in the epidemiological and treatment strategies used
between the two registries, which were performed 7 years apart.
Methods
The CZECH-1 registry was performed from 1 to 30 November
2005 in all 21 cardiocentres (percutaneous coronary interven-
tion [PCI] centres) open at the time in the Czech Republic. AllFig. 1 – The location of the centres that participated in the CZECH-
CZECH-2 registries (4 cardiocentres represented by black asteris
figure legend, the reader is referred to the web version of the arregional community hospitals (n = 15) without catheterization
availability in the two counties of the Czech Republic also
participated. The CZECH-2 registry was performed in October
and November 2012 in the four counties of the Czech Republic,
encompassing 28 regional hospitals without catheterization
availability and four cardiocentres with catheterization labo-
ratories. The locations of the participating centres in both
registries are shown in Fig. 1. All regional hospitals and two
cardiocentres in South Bohemian and Liberec counties
participated in both registries, covering a population of 1
million inhabitants.
The inclusion criteria were the same for entry into both
registries: hospital admission with a diagnosis of ST segment
elevation myocardial infarction (STEMI), non-ST elevation
myocardial infarction (NSTEMI), unstable angina pectoris
(UAP), acute heart failure in patients with known coronary
artery disease (CAD), chest pain with suspected ACS, resusci-
tation in the prehospital phase or another initial diagnosis that
was conﬁrmed as ACS during hospitalization.
In-hospital mortality was evaluated in all the patients. The
ﬁnal diagnosis and conﬁrmation or exclusion of ACS were
performed according to the criteria for and deﬁnition of ACS.1 (left, 21 cardiocentres represented with blue asterisks) and
ks). (For interpretation of the references to colour in this
ticle.)
Fig. 2 – Initial diagnosis of the patients admitted to the
CZECH-1 (blue bars) and CZECH-2 registries (red bars). (For
interpretation of the references to colour in this figure legend,
the reader is referred to the web version of the article.)
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MI) was based on the development of new pathologic Q waves
in two continuous leads on electrocardiography (ECG). The
estimated incidence of conﬁrmed ACS was based on the
number of inhabitants in the representative area of the South
Bohemian and Liberec counties that participated in both
registries according to the Czech Statistical Ofﬁce [1].
Standard descriptive statistics were applied to the analyses,
including absolute and relative frequencies for categorical
variables and means  standard deviation for continuous
variables. The statistical signiﬁcance of differences among
the groups of the patients was calculated using the maximum
likelihood chi-squared test for categorical variables and analysis
of variance (ANOVA) for continuous variables. The level of
statistical signiﬁcance was set at p ≤ 0.05; SPSS 19 for Windows
(version 19.0.1; IBM Corp., 2010) was used for the analysis.
Results
A total of 1921 and 1221 patients were enrolled in the CZECH-1
and CZECH-2 registries, respectively. There were 41.3 and
36.9% of the female subjects in the respective registries
( p = 0.027). Patients in the CZECH-2 registry were older than
those enrolled in CZECH-1 (68  12 vs. 66  12 years; p < 0.001).
Additional clinical characteristics of the patients in both
registries are shown in Table 1.
Diagnosis on admission
The major initial diagnosis in the CZECH-1 registry was UAP in
29% of the patients, whereas most patients in the CZECH-2
registry were admitted for chest pain thought to be due to ACS
(36%). There were no signiﬁcant differences in the percentage
of the patients initially diagnosed with STEMI between the
registries (24.3 vs. 22.1%, p ≥ 0.05). Statistical differences were
observed in the initial diagnosis of different types of ACS
without ST elevation (NSTE-ACS). Patients in the CZECH-2
registry were also more frequently admitted for acute heartTable 1 – Comparison of the clinical characteristics of the
patients enrolled in the CZECH-1 and CZECH-2 registries.
Clinical characteristics CZECH-1 CZECH-2 p
BMI (kg/m2) ≤20 1.5% 1.6% 0.859
20.1–25 21.9% 21.6%
25.1–3.0 43.2% 44.7%
≥30.1 32.3% 33.3%
Smoking Non-smoker 45.5% 43%
Active smoker 13.9% 26.7% <0.001
Ex-smoker 40.6% 30.3%
Diabetes Type 2 32.0% 34.4% 0.159
Dyslipidaemia 39.7% 47.6% <0.001
Hypertension 69.3% 71.7% 0.281
Atrial ﬁbrillation 13.0% 13.3% 0.814
History of Stroke 10.7% 8.4% 0.031
IM 26.9% 24.7% 0.168
PCI 15.4% 20.4% <0.001
CABG 7.4% 9.6% 0.034failure in the presence of CAD (2.1 vs. 9.1%; p < 0.001). The
different initial diagnoses at admission are shown in Fig. 2.
Diagnosis at discharge
ACS was not conﬁrmed during hospitalization in 30.5 and
30.1% ( p = 0.635) of the patients in the CZECH-1 and CZECH-2
registries, respectively. The proportion of the patients in
whom a different type of ACS was conﬁrmed at discharge is
shown in Fig. 3.
Reperfusion strategy in cases involving STEMI
Urgent angiography was performed in 92% of the patients in
the CZECH-1 registry and in 94% of those in CZECH-2 ( p > 0.05).
The time interval (median) from the onset of chest pain to the
ﬁrst diagnostic ECG was 150 min (69–420 min for the 25–75th
percentile) in the CZECH-1 registry, and 150 min (69–455 minFig. 3 – Final diagnosis in patients admitted to the CZECH-1
(blue bars) and CZECH-2 registries (red bars). (For
interpretation of the references to colour in this figure legend,
the reader is referred to the web version of the article.)
Fig. 4 – Differences in the estimated incidence of ACS between the CZECH-1 and CZECH-2 registries in South Bohemian and
Liberec counties.
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interval from ECG to catheterization in the two registries was
70 (60–180 min for the 25–75th percentile) and 85 min (58–
128 min for the 25–75th percentile; p = 0.289), respectively.
Invasive treatment in the patients with ACS without ST
elevation
Coronary angiography during hospitalization was performed
in 85 and 65% of the patients with NSTEMI in the CZECH-1 and
CZECH-2 registries, respectively ( p < 0.01); of these, 75 and 71%
of the patients underwent PCI ( p > 0.05), and 18 and 17%
underwent a coronary artery bypass graft (CABG). Coronary
angiography was performed in 72 and 66% of the patients with
UAP in the CZECH-1 and CZECH-2 registries, respectively
( p < 0.05); this was followed by PCI in 58 and 61% of the
patients ( p > 0.05). Differences in the indications for coronary
angiography during hospitalization were observed between
the cardiocentres with PCI capability and the regional
hospitals (94 vs. 55% for NSTEMI [p < 0.001] and 98 vs. 52%
for UAP [p < 0.001], respectively).
Mortality
The in-hospital mortality rates in the entire CZECH-1 and
CZECH-2 populations were 4.4 and 4.2% ( p = 0.805), respec-
tively. In patients with conﬁrmed myocardial infarction (MI)
according to the development of pathological Q waves on ECG
at discharge, the in-hospital mortality rates were 4.7 and 3.8%
( p = 0.497) for non-Q-IM, and 10.3 and 10.7% ( p = 0.870) for Q-
IM. The in-hospital mortality of the patients with STEMI
treated by primary PCI in the CZECH-1 and CZECH-2 registries
was 5.5 and 5.1% ( p = 0.625), respectively. The in-hospital
mortality and 30-day mortality of all the patients with STEMI
in the CZECH-2 registry were 6.1 and 7.3%, respectively.
Pharmacological treatment
In the patients with conﬁrmed ACS, the following medications
were administered in the CZECH-1 and CZECH-2 registries atdischarge: aspirin (95 vs. 94%; p = NS), clopidogrel (60 vs. 76.4%;
p < 0.001), beta-blockers (78 vs. 78%; p > 0.05), angiotensin-
converting enzyme (ACE) inhibitors (50 vs. 78%; p < 0.001) and
statins (75 vs. 90%; p < 0.001).
Incidence
The estimated incidence of conﬁrmed ACS based on the
number of inhabitants living in the two counties of the Czech
Republic that participated in the CZECH-1 and -2 registries was
3248 and 2149 cases/million inhabitants/year, respectively.
The estimated incidence of conﬁrmed MI in the CZECH-1
and -2 registries was 1960 and 1680 cases/million inhabitants/
year, whereas the estimated incidence of STEMI was 661 and
652 cases/million inhabitants/year, respectively. Differences
in the estimated incidence of ACS between the registries in
the two counties are shown in Fig. 4. A similar estimated
incidence of STEMI was observed in both registries and
counties; however, differences in the estimated incidence of
NSTEMI and UAP were observed.
Discussion
This study compared two large registries that were performed
in the Czech Republic at a 7-year interval; both studies enrolled
patients with an initial diagnosis of ACS. Although a different
number of regional and tertiary hospitals participated in the
CZECH-1 and CZECH-2 registries, both had the same inclusion
criteria in terms of an initial diagnosis of ACS, and both
enrolled all hospitalized patients within a deﬁned period.
Furthermore, all hospitals in the two counties (South
Bohemian and Liberec) of the Czech Republic, covering a
population of 1 million inhabitants, participated in both
registries. Therefore, this comparison has the potential to
identify the trends in the epidemiology and treatment of
unselected populations with an initial diagnosis of ACS.
When the basic clinical characteristics of the patients were
compared between the registries, there was a higher mean age
of the patients in the CZECH-2 registry. This difference was
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aged 40–60 years (29.8 vs. 23.0%) and an increased number of
octogenarians (11.2 vs. 19.2%). An increasing number of
patients with previous revascularization were also hospital-
ized with the suspicion of ACS. Surprisingly, more patients in
the CZECH-2 registry were also active smokers.
ACS was excluded in 30% of the admitted patients in both
registries. Only a small number of previous registries have
included data from unselected patients admitted with the
suspicion of ACS. In the Global Registry of Acute Coronary
Events (GRACE) and Canadian Registry of Acute Coronary
Events (CANRACE) registries, 14% of the patients did not have a
ﬁnal diagnosis of ACS [6]. However, the inclusion criteria for
these registries differed from those in the current study,
because at least one positive biomarker, ECG changes or a
documented history of coronary artery disease, was required
for inclusion. Therefore, because determining the appropriate
diagnoses is challenging, it is clear that a high proportion of
the patients are still admitted with possible ACS during clinical
practice, in whom ACS is later excluded.
Most patients with STEMI in both the CZECH-1 and CZECH-
2 registries underwent urgent angiography with primary PCI.
The Czech Republic has one of the highest percentages of the
patients with STEMI who undergo primary PCI and numbers of
primary PCI per million inhabitants among the European
countries [7,8]. Approximately 25% of the patients with STEMI
presented to a regional hospital; emergency medical personnel
then directly referred most of these to a cardiocentre. This
shows good organization of the emergency network when
handling patients diagnosed with STEMI. Longer time interval
from ECG to catheterization laboratory in the CZECH-2 registry
can be explained by the different proportions of regional
hospitals and cardiocentres in both registries with longer
transport distances in the CZECH-2 registry.
The main limitation of this study is the different propor-
tions of regional hospitals and cardiocentres that participated
in the CZECH-1 and -2 registries. In the CZECH-1 registry,
cardiocentres dominated in participation. This might inﬂu-
ence comparisons of the clinical characteristics and treatment
strategies in patients with ACS without ST elevation. Patients
admitted at a regional hospital for NSTEMI and UAP were
signiﬁcantly older and had more comorbidities than did
patients admitted to a cardiocentre. Differences in the
indications for coronary angiography in patients with NSTEMI
and UAP during hospitalization were also clearly observed
between the cardiocentres with PCI capability and regional
hospitals. This could be explained by the following factors:
ﬁrst, 20% of the patients admitted to regional hospitals
undergo coronary angiography electively after discharge;
second, 12.7% of the patients in the CZECH-2 registry refused
to be transferred from a regional hospital to a PCI centre; and
third, patients with NSTE-ACS had several comorbidities and
were considered unsuitable for transfer to a PCI centre by the
physicians at regional hospitals. A similar approach for the
invasive management of the patients with NSTE-ACS admit-
ted to non-PCI centres was seen in the Acute coronary
syndromes – Longitudinal Evaluation of Real-life Treatment
in non-PCI hospitals in the Czech Republic (ALERT-CZ) registry
[9]. In ALERT-CZ, coronary angiography was performed during
the initial hospitalization or later in 72.5% of the 4625 patientswith non-NSTE-ACS. Another limitation of the current study is
the relatively short period of data collection in both the
CZECH-1 (1 month) and -2 registries (2 months). Therefore, the
reported annual incidence of ACS must be regarded as an
estimated incidence. This might partially explain the different
incidences of ACS in Liberec County between 2005 and 2012. In
addition, the difference in the estimated incidence of ACS
among the counties is caused mainly by a decreased number
of admitted patients with a ﬁnal diagnosis of UAP. Therefore, it
is possible that more patients presenting with chest pain but
without positive cardiac markers and ECG changes were not
admitted during the CZECH-2 registry.
Despite the differences in the clinical characteristics and
invasive approaches to NSTE-ACS between the CZECH-1 and -2
registries, the in-hospital mortality of all the patients and the
deﬁnitive diagnosis of Q-MI or non-Q-MI remained consistent.
Furthermore, there was a trend for greater use of recom-
mended evidence-based medication at discharge in patients
with conﬁrmed ACS.
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